BamSEC and AlphaSense Join Forces
Learn More

Oruka Therapeutics Inc. – Indentures

NASDAQ: ORKA    
Share price (6/2/26): $55.23    
Market cap (6/2/26): $3.331 billion

Indentures Filter

EX-4.6
from 10-K 12 pages Oruka Therapeutics, Inc. Warrant to Purchase Common Stock
12/34/56
EX-4.1
from 8-K 15 pages This Warrant and the Shares of Common Stock Issuable Upon the Exercise of This Warrant (The “Securities”) Have Not Been Registered Under the Securities Act of 1933, as Amended (The “Securities Act”), or the Securities Laws of Any State of the United States. the Securities Have Been Acquired for Investment and May Not Be Sold, Transferred or Assigned Unless (I) Such Securities Have Been Registered for Sale Pursuant to the Securities Act, (II) Such Securities May Be Sold Pursuant to Rule 144 Under the Securities Act, (III) the Company Has Received an Opinion of Counsel Reasonably Satisfactory to It That Such Transfer May Lawfully Be Made Without Registration Under the Securities Act, or (IV) the Securities Are Transferred Without Consideration to an Affiliate of Such Holder or a Custodial Nominee (Which for the Avoidance of Doubt Shall Require Neither Consent Nor the Delivery of an Opinion). Form of Pre-Funded Warrant to Purchase Common Stock
12/34/56
EX-4.5
from 10-Q 11 pages Oruka Therapeutics, Inc. Warrant to Purchase Common Stock
12/34/56
EX-4.3
from 10-K 12 pages Oruka Therapeutics, Inc. Pre-Funded Warrant to Purchase Common Stock
12/34/56
EX-4.1
from 10-K 4 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934, as Amended Description of Capital Stock
12/34/56
EX-4.1
from 8-K 13 pages Form of Pre-Funded Warrant to Purchase Common Stock
12/34/56
EX-4.3
from S-4 27 pages Investors’ Rights Agreement
12/34/56
EX-4.1
from 8-K 18 pages Pre-Funded Common Stock Purchase Warrant ARCA Biopharma, Inc
12/34/56
EX-4.6
from S-3 19 pages ARCA Biopharma, Inc. and , as Warrant Agent Form of Debt Securities Warrant Agreement Dated as of ARCA Biopharma, Inc. Form of Debt Securities Warrant Agreement Article 1 Issuance of Warrants and Execution And
12/34/56
EX-4.5
from S-3 20 pages ARCA Biopharma, Inc. and , as Warrant Agent Form of Preferred Stock Warrant Agreement Dated as of ARCA Biopharma, Inc. Form of Preferred Stock Warrant Agreement Article 1 Issuance of Warrants and Execution and Delivery of Warrant Certificates
12/34/56
EX-4.4
from S-3 20 pages ARCA Biopharma, Inc. and , as Warrant Agent Form of Common Stock Warrant Agreement Dated as of ARCA Biopharma, Inc. Form of Common Stock Warrant Agreement Article 1 Issuance of Warrants and Execution and Delivery of Warrant Certificates
12/34/56
EX-4.3
from S-3 55 pages ARCA Biopharma, Inc., Issuer and [Trustee], Trustee Indenture Dated as of [·], 20__ Debt Securities
12/34/56
EX-4.7
from 10-K 4 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.2
from 10-Q 1 page Indenture or similar
12/34/56
EX-4.6
from S-3 20 pages ARCA Biopharma, Inc. and , as Warrant Agent Form of Debt Securities Warrant Agreement Dated as of [ ], 20 ARCA Biopharma, Inc. Form of Debt Securities Warrant Agreement
12/34/56
EX-4.5
from S-3 24 pages ARCA Biopharma, Inc. and , as Warrant Agent Form of Preferred Stock Warrant Agreement Dated as of [ ], 20 ARCA Biopharma, Inc. Form of Preferred Stock Warrant Agreement Article 1 Issuance of Warrants and Execution and Delivery of Warrant Certificates
12/34/56
EX-4.4
from S-3 23 pages ARCA Biopharma, Inc. and , as Warrant Agent Form of Common Stock Warrant Agreement Dated as of [ ], 20 ARCA Biopharma, Inc. Form of Common Stock Warrant Agreement Article 1 Issuance of Warrants and Execution and Delivery of Warrant Certificates
12/34/56
EX-4.3
from S-3 54 pages ARCA Biopharma, Inc, Issuer and [Trustee], Trustee Indenture Dated as of [●], 20 Debt Securities
12/34/56
EX-4.2
from 8-K 9 pages Exhibit B-2 Form of Warrant
12/34/56
EX-4.1
from 8-K 9 pages Exhibit B-1 Form of Warrant
12/34/56